Dangerously low blood sugar affects about one in 10 babies born too early. Untreated, it can cause permanent harm.
Researchers from New Zealand tested the gel therapy in 242 babies under their care and, based on the results, say it should now be a first-line treatment.
The researcher’s work is published in The Lancet.
Dextrose gel treatment costs just over $1.5 per baby and is simpler to administer than glucose via a drip, say Prof. Jane Harding and her team at the University of Auckland.
Current treatment typically involves extra feeding and repeated blood tests to measure blood sugar levels.
But many babies are admitted to intensive care and given intravenous glucose because their blood sugar remains low – a condition doctors call hypoglycaemia.
The study assessed whether treatment with dextrose gel was more effective than feeding alone at reversing hypoglycaemia.
Sydney has welcomed 2025 with a spectacular fireworks display - cheers erupted as the clock struck midnight…
Following an eight-year legal battle, Angelina Jolie and Brad Pitt have reached a divorce settlement,…
Former President Jimmy Carter died on December 29 at the age of 100 after spending several…
Georgia’s outgoing president Salome Zourabichvili refused to step down on December 29, saying she was…
The bald eagle has been officially declared the national bird of the United States, after…
Dozens of passengers have survived a crash involving a plane carrying 69 people in Kazakhstan,…